609 related articles for article (PubMed ID: 32113513)
1. Screening for diabetic retinopathy: new perspectives and challenges.
Vujosevic S; Aldington SJ; Silva P; Hernández C; Scanlon P; Peto T; Simó R
Lancet Diabetes Endocrinol; 2020 Apr; 8(4):337-347. PubMed ID: 32113513
[TBL] [Abstract][Full Text] [Related]
2. Satisfaction of patients and primary care professionals with a teleophthalmology-based screening programme for diabetic retinopathy in a rural area in Castilla y León, Spain.
Valpuesta Martin Y; Pacheco Callirgos GE; Maroto Martín TM; Piriz Veloso M; Hernández Santamaría S; López Gálvez MI
Rural Remote Health; 2020 Jan; 20(1):5180. PubMed ID: 31941342
[TBL] [Abstract][Full Text] [Related]
3. Teleophthalmology screening for diabetic retinopathy through mobile imaging units within Canada.
Boucher MC; Desroches G; Garcia-Salinas R; Kherani A; Maberley D; Olivier S; Oh M; Stockl F
Can J Ophthalmol; 2008 Dec; 43(6):658-68. PubMed ID: 19020631
[TBL] [Abstract][Full Text] [Related]
4. Use of personalised risk-based screening schedules to optimise workload and sojourn time in screening programmes for diabetic retinopathy: A retrospective cohort study.
Ochs A; McGurnaghan S; Black MW; Leese GP; Philip S; Sattar N; Styles C; Wild SH; McKeigue PM; Colhoun HM;
PLoS Med; 2019 Oct; 16(10):e1002945. PubMed ID: 31622334
[TBL] [Abstract][Full Text] [Related]
5. Telemedicine-based digital retinal imaging vs standard ophthalmologic evaluation for the assessment of diabetic retinopathy.
Li Z; Wu C; Olayiwola JN; Hilaire DS; Huang JJ
Conn Med; 2012 Feb; 76(2):85-90. PubMed ID: 22670358
[TBL] [Abstract][Full Text] [Related]
6. Diabetic retinopathy screening in the emerging era of artificial intelligence.
Grauslund J
Diabetologia; 2022 Sep; 65(9):1415-1423. PubMed ID: 35639120
[TBL] [Abstract][Full Text] [Related]
7. Diabetic retinopathy. Screening and prevention of blindness. A doctoral thesis.
Kristinsson JK
Acta Ophthalmol Scand Suppl; 1997; (223):1-76. PubMed ID: 9559048
[TBL] [Abstract][Full Text] [Related]
8. Individualised screening for diabetic retinopathy: the ISDR study-rationale, design and methodology for a randomised controlled trial comparing annual and individualised risk-based variable-interval screening.
Broadbent DM; Sampson CJ; Wang A; Howard L; Williams AE; Howlin SU; Appelbe D; Moitt T; Cheyne CP; Rahni MM; Kelly J; Collins J; García-Fiñana M; Stratton IM; James M; Harding SP;
BMJ Open; 2019 Jun; 9(6):e025788. PubMed ID: 31213445
[TBL] [Abstract][Full Text] [Related]
9. Personalising screening of sight-threatening diabetic retinopathy - qualitative evidence to inform effective implementation.
Byrne P; Thetford C; Gabbay M; Clarke P; Doncaster E; Harding SP;
BMC Public Health; 2020 Jun; 20(1):881. PubMed ID: 32513143
[TBL] [Abstract][Full Text] [Related]
10. Sight-threatening diabetic retinopathy at presentation to screening services in Fiji.
Damato EM; Murray N; Szetu J; Sikivou BT; Emma S; McGhee CN
Ophthalmic Epidemiol; 2014 Oct; 21(5):318-26. PubMed ID: 25157913
[TBL] [Abstract][Full Text] [Related]
11. The Role of Retinal Imaging and Portable Screening Devices in Tele-ophthalmology Applications for Diabetic Retinopathy Management.
DeBuc DC
Curr Diab Rep; 2016 Dec; 16(12):132. PubMed ID: 27841014
[TBL] [Abstract][Full Text] [Related]
12. Screening for diabetic retinopathy: a relative cost-effectiveness analysis of alternative modalities and strategies.
Sculpher MJ; Buxton MJ; Ferguson BA; Spiegelhalter DJ; Kirby AJ
Health Econ; 1992 Apr; 1(1):39-51. PubMed ID: 1342628
[TBL] [Abstract][Full Text] [Related]
13. Strategies to Tackle the Global Burden of Diabetic Retinopathy: From Epidemiology to Artificial Intelligence.
Wong TY; Sabanayagam C
Ophthalmologica; 2020; 243(1):9-20. PubMed ID: 31408872
[TBL] [Abstract][Full Text] [Related]
14. Screening intervals for diabetic retinopathy and incidence of visual loss: a systematic review.
Echouffo-Tcheugui JB; Ali MK; Roglic G; Hayward RA; Narayan KM
Diabet Med; 2013 Nov; 30(11):1272-92. PubMed ID: 23819487
[TBL] [Abstract][Full Text] [Related]
15. Rates of referable eye disease in the Scottish National Diabetic Retinopathy Screening Programme.
Looker HC; Nyangoma SO; Cromie DT; Olson JA; Leese GP; Black MW; Doig J; Lee N; Lindsay RS; McKnight JA; Morris AD; Pearson DW; Philip S; Wild SH; Colhoun HM; ;
Br J Ophthalmol; 2014 Jun; 98(6):790-5. PubMed ID: 24599419
[TBL] [Abstract][Full Text] [Related]
16. Incidence of sight-threatening retinopathy in Type 1 diabetes in a systematic screening programme.
Younis N; Broadbent DM; Harding SP; Vora JP
Diabet Med; 2003 Sep; 20(9):758-65. PubMed ID: 12925058
[TBL] [Abstract][Full Text] [Related]
17. Modelling the cost-effectiveness of adopting risk-stratified approaches to extended screening intervals in the national diabetic retinopathy screening programme in Scotland.
Scotland G; McKeigue P; Philip S; Leese GP; Olson JA; Looker HC; Colhoun HM; Javanbakht M
Diabet Med; 2016 Jul; 33(7):886-95. PubMed ID: 27040994
[TBL] [Abstract][Full Text] [Related]
18. The internist's role in managing diabetic retinopathy: screening for early detection.
Sinclair SH; Delvecchio C
Cleve Clin J Med; 2004 Feb; 71(2):151-9. PubMed ID: 14982198
[TBL] [Abstract][Full Text] [Related]
19. Fundamental principles of an effective diabetic retinopathy screening program.
Lanzetta P; Sarao V; Scanlon PH; Barratt J; Porta M; Bandello F; Loewenstein A;
Acta Diabetol; 2020 Jul; 57(7):785-798. PubMed ID: 32222818
[TBL] [Abstract][Full Text] [Related]
20. Role of frequency doubling technology perimetry in screening of diabetic retinopathy.
Parikh R; Naik M; Mathai A; Kuriakose T; Muliyil J; Thomas R
Indian J Ophthalmol; 2006 Mar; 54(1):17-22. PubMed ID: 16531665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
